Haringman J J, Smeets T J M, Reinders-Blankert P, Tak P P
Division of Clinical Immunology and Rheumatology F4-218, Department of Internal Medicine, Academic Medical Centre/University of Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, The Netherlands.
Ann Rheum Dis. 2006 Mar;65(3):294-300. doi: 10.1136/ard.2005.037176. Epub 2005 Aug 17.
Chemokine receptors and chemokines have a crucial role in leucocyte recruitment into inflamed tissue.
To examine the expression of an extensive number of chemokines and receptors in a unique bank of paired samples of synovial tissue (ST) and peripheral blood (PB) from patients with different forms of arthritis to assist in identifying suitable targets for therapeutic intervention.
Synovial biopsy specimens were obtained from 23 patients with rheumatoid arthritis (RA), 16 with osteoarthritis, and 8 with reactive arthritis. ST chemokine (CCL2/MCP-1, CCL5/RANTES, CCL7/MCP-3, CCL8/MCP-2, CCL14/HCC-1, CCL15/HCC-2, CCL16/HCC-4), chemokine receptor (CCR1, CCR2b, CCR5, CXCR4), and CD13 expression was analysed by immunohistochemistry and two colour immunofluorescence. Chemokine receptor expression (CCR1, CCR3, CCR5, CCR6, CCR7) on PB cells was studied by flow cytometry. Non-parametric tests were used for statistical analysis.
Abundant expression of CCR1, CXCR4, and CCR5 was found in all forms of arthritis, with a specific increase of CCL5 and CCL15 in RA. CCL7, CCL8, CCL14, CCL15, and CCL16 were detected for the first time in ST. The results for PB analysis were comparable among different arthritides. Interestingly, compared with healthy controls, significantly lower expression of CCR1 (p<0.005) and CCR5 (p<0.05) by PB monocytes in the patient groups was seen.
A variety of chemokines and receptors might have an important role in several inflammatory joint disorders. Although other receptors are involved as well, migration of CCR1(+) and CCR5(+) cells towards the synovial compartment may play a part in the effector phase of various forms of arthritis.
趋化因子受体和趋化因子在白细胞募集到炎症组织中起关键作用。
检测不同类型关节炎患者滑膜组织(ST)和外周血(PB)配对样本库中大量趋化因子和受体的表达,以协助确定治疗干预的合适靶点。
从23例类风湿关节炎(RA)患者、16例骨关节炎患者和8例反应性关节炎患者获取滑膜活检标本。通过免疫组织化学和双色免疫荧光分析ST趋化因子(CCL2/MCP-1、CCL5/RANTES、CCL7/MCP-3、CCL8/MCP-2、CCL14/HCC-1、CCL15/HCC-2、CCL16/HCC-4)、趋化因子受体(CCR1、CCR2b、CCR5、CXCR4)和CD13的表达。通过流式细胞术研究PB细胞上趋化因子受体(CCR1、CCR3、CCR5、CCR6、CCR7)的表达。采用非参数检验进行统计分析。
在所有类型关节炎中均发现CCR1、CXCR4和CCR5大量表达,RA中CCL5和CCL15有特异性增加。首次在ST中检测到CCL7、CCL8、CCL14、CCL15和CCL16。不同关节炎类型的PB分析结果具有可比性。有趣的是,与健康对照相比,患者组PB单核细胞中CCR1(p<0.005)和CCR5(p<0.05)的表达明显降低。
多种趋化因子和受体可能在几种炎症性关节疾病中起重要作用。尽管也涉及其他受体,但CCR1(+)和CCR5(+)细胞向滑膜腔的迁移可能在各种类型关节炎的效应阶段起作用。